These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32396749)

  • 41. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
    Lomelino CL; Mahon BP; McKenna R; Carta F; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):976-81. PubMed ID: 26810836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration.
    Eloranta K; Pihlajoki M; Liljeström E; Nousiainen R; Soini T; Lohi J; Cairo S; Wilson DB; Parkkila S; Heikinheimo M
    Front Oncol; 2023; 13():1118268. PubMed ID: 36776327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
    Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
    Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX.
    Dvořanová J; Kugler M; Holub J; Šícha V; Das V; Nekvinda J; El Anwar S; Havránek M; Pospíšilová K; Fábry M; Král V; Medvedíková M; Matějková S; Lišková B; Gurská S; Džubák P; Brynda J; Hajdúch M; Grüner B; Řezáčová P
    Eur J Med Chem; 2020 Aug; 200():112460. PubMed ID: 32505851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles.
    Nocentini A; Trallori E; Singh S; Lomelino CL; Bartolucci G; Di Cesare Mannelli L; Ghelardini C; McKenna R; Gratteri P; Supuran CT
    J Med Chem; 2018 Dec; 61(23):10860-10874. PubMed ID: 30433782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.
    Abdel Gawad NM; Amin NH; Elsaadi MT; Mohamed FMM; Angeli A; De Luca V; Capasso C; Supuran CT
    Bioorg Med Chem; 2016 Jul; 24(13):3043-3051. PubMed ID: 27234893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
    Robertson N; Potter C; Harris AL
    Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity.
    Tanini D; Ricci L; Capperucci A; Di Cesare Mannelli L; Ghelardini C; Peat TS; Carta F; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111586. PubMed ID: 31401537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas.
    Akocak S; Alam MR; Shabana AM; Sanku RK; Vullo D; Thompson H; Swenson ER; Supuran CT; Ilies MA
    J Med Chem; 2016 May; 59(10):5077-88. PubMed ID: 27144971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors.
    Salerno S; Barresi E; Amendola G; Berrino E; Milite C; Marini AM; Da Settimo F; Novellino E; Supuran CT; Cosconati S; Taliani S
    J Med Chem; 2018 Jul; 61(13):5765-5770. PubMed ID: 29912561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cytotoxic, apoptotic and oxidative effects of carbonic anhydrase IX inhibitor on colorectal cancer cells.
    Tülüce Y; Ahmed BA; Koyuncu İ; Durgun M
    J Bioenerg Biomembr; 2018 Apr; 50(2):107-116. PubMed ID: 29520697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX.
    Abdel-Aziz AA; El-Azab AS; Abu El-Enin MA; Almehizia AA; Supuran CT; Nocentini A
    Bioorg Chem; 2018 Oct; 80():706-713. PubMed ID: 30064081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
    Angeli A; Carta F; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions.
    Coviello V; Marchi B; Sartini S; Quattrini L; Marini AM; Simorini F; Taliani S; Salerno S; Orlandi P; Fioravanti A; Desidero TD; Vullo D; Da Settimo F; Supuran CT; Bocci G; La Motta C
    J Med Chem; 2016 Jul; 59(13):6547-52. PubMed ID: 27305384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs.
    van Kuijk SJA; Parvathaneni NK; Niemans R; van Gisbergen MW; Carta F; Vullo D; Pastorekova S; Yaromina A; Supuran CT; Dubois LJ; Winum JY; Lambin P
    Eur J Med Chem; 2017 Feb; 127():691-702. PubMed ID: 27823879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells.
    Sarnella A; Ferrara Y; Albanese S; Omodei D; Cerchia L; De Simone G; Supuran CT; Zannetti A
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism.
    Angeli A; Tanini D; Capperucci A; Malevolti G; Turco F; Ferraroni M; Supuran CT
    Bioorg Chem; 2018 Dec; 81():642-648. PubMed ID: 30253337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.